Ayman Mithqal
Papers
1
Total Citations
11
H-Index
1
About
Ayman Mithqal is a researcher whose work sits at the critical intersection of urologic oncology and health economics, with a particular focus on optimizing treatment strategies for small renal masses. His most-cited study, a rigorous cost-effectiveness analysis comparing percutaneous microwave ablation to robotic-assisted partial nephrectomy, has garnered 11 citations and provides essential data for clinical decision-making in an era of rising healthcare costs. This work exemplifies his broader contribution: using quantitative modeling to evaluate not just clinical outcomes, but the real-world value of emerging technologies. By systematically assessing the trade-offs between minimally invasive ablation and robotic surgery, Mithqal offers surgeons and policymakers a framework for balancing efficacy, patient morbidity, and financial sustainability. His research is particularly valuable for trainees navigating the expanding arsenal of nephron-sparing treatments, as it moves beyond simple efficacy comparisons to address the practical constraints of resource allocation. Through this focused body of work, Mithqal has established himself as a thoughtful voice in the ongoing debate over how to deliver high-value cancer care in an increasingly technology-driven field.
Research Focus
Key Achievements
Top Papers
- 1